Horse Chestnut Extract
CAS 8053-39-2
Horse Chestnut Extract (CAS 8053-39-2) is a pharmaceutical compound with 0 bioactivity targets and 673 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
HORSE CHESTNUT EXTRACT is linked to DTXSID201042453 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Horse Chestnut Extract used for in pharmaceutical contexts?
Horse Chestnut Extract (CAS 8053-39-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Horse Chestnut Extract?
Horse Chestnut Extract has 673 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal distension, Abdominal pain, Abdominal pain upper, Activated partial thromboplastin time prolonged, Anaemia. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Horse Chestnut Extract also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Aesculus Hippocastanum Extract with EU status "permitted".
What clinical phase is Horse Chestnut Extract in?
No phase 1-4 clinical development badge is rendered for Horse Chestnut Extract because the matched compound identifier rows do not contain a max-phase value.